Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
600 participants
INTERVENTIONAL
2012-05-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study participants will be randomized to receive either a brief quitline facilitation intervention , or a control intervention of a brief stop-smoking message.
The study will also compare healthcare costs and utilization in the first six months following hospitalization between the two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoking Interventions for Hospital Patients
NCT01177176
Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers
NCT03096145
Enhancing Smoker Utilization of the Minnesota Quitline Through Support Persons
NCT01311830
Intervention for Support Persons to Help Smokers Quit
NCT00379054
Support Person Intervention to Promote a Smoking Helpline
NCT01331226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quitline facilitation intervention
brief quitline facilitation intervention given
Quitline facilitation intervention
brief quitline facilitation intervention
Stop-smoking intervention
brief review of tips to maintain smoking abstinence, using brochure
Brief stop-smoking intervention
brief review of tips to help maintain smoking abstinence, using brochure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quitline facilitation intervention
brief quitline facilitation intervention
Brief stop-smoking intervention
brief review of tips to help maintain smoking abstinence, using brochure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Warner
Associate Director of Clinical and Translational Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Warner, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nolan MB, Borah BJ, Moriarty JP, Warner DO. Association between smoking cessation and post-hospitalization healthcare costs: a matched cohort analysis. BMC Health Serv Res. 2019 Dec 2;19(1):924. doi: 10.1186/s12913-019-4777-7.
Nolan MB, Borah BJ, Moriarty JP, Warner DO. Economic Analysis of a Geographically Defined Cohort of Hospitalized Patients Who Smoke. Mayo Clin Proc. 2018 Aug;93(8):1034-1042. doi: 10.1016/j.mayocp.2018.02.022. Epub 2018 Jul 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-002207
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.